Administration of SARS-CoV-2 non-replicating viral vector vaccine

Administration of vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein (procedure)

procedure

£1.00

Supplier: international · SCTID 1157107003

Also known as (14)

2019 novel coronavirus non-replicating viral vector immunisation
2019 novel coronavirus non-replicating viral vector immunization
2019 novel coronavirus non-replicating viral vector vaccination
2019-nCoV non-replicating viral vector immunisation
2019-nCoV non-replicating viral vector immunization
2019-nCoV non-replicating viral vector vaccination
Administration of vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein
COVID-19 non-replicating viral vector immunisation
COVID-19 non-replicating viral vector immunization
COVID-19 non-replicating viral vector vaccination
SARS-CoV-2 non-replicating viral vector immunisation
SARS-CoV-2 non-replicating viral vector immunization
SARS-CoV-2 non-replicating viral vector vaccination
Severe acute respiratory syndrome coronavirus 2 non-replicating viral vector vaccination